latest news in companies

US and China Finalize TikTok Spinoff Deal to Avert Nationwide Ban

US and China Finalize TikTok Spinoff Deal to Avert Nationwide Ban

Washington D.C., Thursday, 22 January 2026.
Washington and Beijing have approved TikTok’s spinoff to an Oracle-led consortium, averting a ban. The historic deal reportedly values the unit at $14 billion, leaving ByteDance with a minority stake.

Capital One to Acquire Fintech Unicorn Brex for $5.15 Billion to Boost Corporate Services

Capital One to Acquire Fintech Unicorn Brex for $5.15 Billion to Boost Corporate Services

McLean, Thursday, 22 January 2026.
Capital One accelerates its fintech consolidation strategy, agreeing to acquire corporate spend unicorn Brex for $5.15 billion to aggressively integrate modern expense management into its enterprise lending portfolio.

OLB Group Unveils AI Platform for Instant E-Commerce and Same-Day Approvals

OLB Group Unveils AI Platform for Instant E-Commerce and Same-Day Approvals

New York, Thursday, 22 January 2026.
OLB Group’s newly launched iStores.com leverages artificial intelligence to enable same-day merchant approval, positioning the fintech firm to capitalize on the projected $16.8 trillion global eCommerce market by 2028.

SpaceX Taps Wall Street Giants for Potential Historic 2026 IPO

SpaceX Taps Wall Street Giants for Potential Historic 2026 IPO

New York, Thursday, 22 January 2026.
Elon Musk’s SpaceX has selected four major banks to lead a 2026 listing, positioning the aerospace giant for what could become the largest initial public offering in history.

Trump Files $5 Billion Lawsuit Against JPMorgan Alleging Politically Motivated Account Closures

Trump Files $5 Billion Lawsuit Against JPMorgan Alleging Politically Motivated Account Closures

New York, Thursday, 22 January 2026.
President Trump seeks $5 billion in damages, accusing JPMorgan and CEO Jamie Dimon of “political debanking” by terminating his accounts following the 2021 Capitol riots.

Laser Photonics Expands Pharmaceutical Presence with $1.3 Million High-Speed Laser System Contract

Laser Photonics Expands Pharmaceutical Presence with $1.3 Million High-Speed Laser System Contract

Orlando, Thursday, 22 January 2026.
On January 22, 2026, Laser Photonics Corporation (NASDAQ: LASE) validated its expanding footprint in the pharmaceutical sector by securing a $1.3 million order for its specialized TD-140 laser drilling system. This contract with a new international client highlights the company’s ability to meet rigorous FDA manufacturing standards, utilizing technology capable of processing 140,000 tablets per hour. For market observers, this deal represents a critical step in revenue diversification and operational growth, signaling that Laser Photonics is successfully translating its industrial laser capabilities into the high-stakes medical manufacturing arena following recent executive leadership adjustments.

Loar Holdings Expands Aerospace Portfolio with $250 Million Acquisition of Harper Engineering

Loar Holdings Expands Aerospace Portfolio with $250 Million Acquisition of Harper Engineering

New York, Thursday, 22 January 2026.
Loar finalized this $250 million cash deal today, securing key aircraft interior technologies and projecting approximately $30 million in tax benefits from the strategic transaction.

Rocket Lab Successfully Begins 2026 Campaign with Open Cosmos Satellite Deployment

Rocket Lab Successfully Begins 2026 Campaign with Open Cosmos Satellite Deployment

Mahia, Thursday, 22 January 2026.
Marking its 80th Electron mission, Rocket Lab successfully deployed Open Cosmos’ first telecom satellites today, signaling a strong start to its 2026 operational calendar.

USA Rare Earth Engages Fluor and WSP to Accelerate Texas Critical Minerals Production

USA Rare Earth Engages Fluor and WSP to Accelerate Texas Critical Minerals Production

Stillwater, Thursday, 22 January 2026.
Selecting Fluor and WSP to lead construction, USA Rare Earth targets an accelerated late 2028 production start for the strategic Round Top deposit, vital for domestic technology and defense.

Immuron Confirmed as Buy Opportunity Following Strong First-Half Revenue Data

Immuron Confirmed as Buy Opportunity Following Strong First-Half Revenue Data

New York, Thursday, 22 January 2026.
Emerging Growth Research has maintained a ‘Buy-Extended’ rating for Immuron Limited, reaffirming a $3.50 price target as of January 22, 2026. This positive outlook is underpinned by tangible financial performance, specifically a 5% increase in global revenue to AUD$4.2 million for the half-year ending December 31, 2025. Crucially, the analysis highlights a 17% revenue surge in the United States and a 13% increase in Australia, driven by robust demand for the company’s flagship travel health supplement, Travelan®. This commercial momentum, further bolstered by the December 2025 launch of the digestive health product ProIBS®, supports the valuation despite standard biopharmaceutical capital risks.